First AD

Second AD

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Michael Schuster, MD

OncLive News Network®

Nilotinib and Dasatinib Versus Imatinib in CML

Changing Treatment Landscape in CML

The Importance of Frequent Monitoring in CML

Is It Okay to Stop Therapy in CML Patients?

Treatment Options in the Relapsed/Refractory Setting